fluorouracil has been researched along with osimertinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, S; Gao, W; Huang, Z; Jiang, J; Jin, P; Lei, Y; Li, B; Li, C; Nice, EC; Peng, L; Qin, S; Shao, J; Xie, K; Xie, N; Zhang, L; Zhou, L | 1 |
1 other study(ies) available for fluorouracil and osimertinib
Article | Year |
---|---|
MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling.
Topics: Acrylamides; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Fluorouracil; Humans; Mice, Inbred BALB C; Mice, Nude; Monocarboxylic Acid Transporters; Oxaliplatin; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Symporters; Up-Regulation | 2019 |